{"id":3233,"date":"2025-01-03T21:58:54","date_gmt":"2025-01-03T20:58:54","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/"},"modified":"2025-01-03T21:58:56","modified_gmt":"2025-01-03T20:58:56","slug":"une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/","title":{"rendered":"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2025\/study-compares-single.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2025\/study-compares-single.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Pour les patients atteints de maladie pulmonaire obstructive chronique (MPOC), le bud\u00e9sonide-glycopyrrolate-formot\u00e9rol n&rsquo;am\u00e9liore pas les r\u00e9sultats cliniques par rapport au fluticasone-umeclidinium-vilanterol, selon une \u00e9tude publi\u00e9e en ligne le 30 d\u00e9cembre dans <i>Le BMJ<\/i>.<\/p>\n<p>William B. Feldman, MD, MPH, du Brigham and Women&rsquo;s Hospital de Boston, et ses coll\u00e8gues ont compar\u00e9 l&rsquo;efficacit\u00e9 et l&rsquo;innocuit\u00e9 du bud\u00e9sonide-glycopyrrolate-formot\u00e9rol, un inhalateur doseur deux fois par jour, et du fluticasone-umeclidinium-vilanterol, un inhalateur doseur une fois par jour. inhalateur de poudre s\u00e8che pour le traitement de la BPCO dans la pratique clinique de routine dans une \u00e9tude de cohorte assortie d&rsquo;un score de propension 1:1 pour les nouveaux utilisateurs. L\u2019\u00e9tude a port\u00e9 sur 20\u00a0388 paires de nouveaux utilisateurs correspondant \u00e0 des scores de propension.<\/p>\n<p>Les chercheurs ont d\u00e9couvert que l&rsquo;incidence d&rsquo;une premi\u00e8re exacerbation mod\u00e9r\u00e9e ou s\u00e9v\u00e8re de la BPCO \u00e9tait plus \u00e9lev\u00e9e chez les patients ayant re\u00e7u du bud\u00e9sonide-glycopyrrolate-formot\u00e9rol (rapport de risque, 1,09\u00a0; intervalle de confiance \u00e0 95\u00a0%, 1,04 \u00e0 1,14\u00a0; nombre n\u00e9cessaire pour nuire, 38) par rapport \u00e0 ceux qui ont re\u00e7u de la fluticasone-umeclidinium-vilanterol, alors que l&rsquo;incidence de premi\u00e8re hospitalisation pour pneumonie \u00e9tait identique entre les groupes (rapport de risque, 1,00\u00a0; intervalle de confiance \u00e0 95\u00a0pour cent, 0,19 \u00e0 1,10). Ceux recevant du bud\u00e9sonide-glycopyrrolate-formot\u00e9rol par rapport au fluticasone-umeclidinium-vilanterol pr\u00e9sentaient un risque plus \u00e9lev\u00e9 de premi\u00e8re exacerbation mod\u00e9r\u00e9e de la BPCO (rapport de risque, 1,07\u00a0; intervalle de confiance \u00e0 95\u00a0%, 1,02 \u00e0 1,12\u00a0; nombre n\u00e9cessaire pour nuire, 54) et d&rsquo;un premier exacerbation s\u00e9v\u00e8re de la BPCO (rapport de risque\u00a0: 1,29\u00a0; intervalle de confiance de 95\u00a0%, 1,12 \u00e0 1,48\u00a0; nombre n\u00e9cessaire pour nuire, 97). Des r\u00e9sultats similaires ont \u00e9t\u00e9 observ\u00e9s dans des analyses de sensibilit\u00e9 pr\u00e9d\u00e9finies.<\/p>\n<p>\u00ab\u00a0Notre \u00e9tude pourrait rassurer les syst\u00e8mes de sant\u00e9 qui cherchent \u00e0 r\u00e9duire les \u00e9missions de gaz \u00e0 effet de serre en r\u00e9duisant l&rsquo;utilisation d&rsquo;inhalateurs-doseurs, car la trith\u00e9rapie \u00e0 inhalateur unique avec l&#8217;empreinte carbone la plus faible (l&rsquo;inhalateur \u00e0 poudre s\u00e8che, fluticasone-umeclidinium-vilanterol) a \u00e9galement \u00e9t\u00e9 associ\u00e9e. avec des r\u00e9sultats cliniques l\u00e9g\u00e8rement am\u00e9lior\u00e9s\u00a0\u00bb, \u00e9crivent les auteurs.<\/p>\n<p>Plusieurs auteurs ont r\u00e9v\u00e9l\u00e9 des liens avec les industries pharmaceutique et des technologies de l\u2019information sur la sant\u00e9.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pour les patients atteints de maladie pulmonaire obstructive chronique (MPOC), le bud\u00e9sonide-glycopyrrolate-formot\u00e9rol n&rsquo;am\u00e9liore pas les<\/p>\n","protected":false},"author":1,"featured_media":3234,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[116,3340,48,3342,49,8,261,3341,47,422],"class_list":["post-3233","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-bpco","tag-compare","tag-etude","tag-inhalateur","tag-les","tag-pour","tag-traitement","tag-tritherapies","tag-une","tag-unique","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Pour les patients atteints de maladie pulmonaire obstructive chronique (MPOC), le bud\u00e9sonide-glycopyrrolate-formot\u00e9rol n&rsquo;am\u00e9liore pas les\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-03T20:58:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-03T20:58:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO\",\"datePublished\":\"2025-01-03T20:58:54+00:00\",\"dateModified\":\"2025-01-03T20:58:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/\"},\"wordCount\":387,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg\",\"keywords\":[\"BPCO\",\"compare\",\"\u00e9tude\",\"inhalateur\",\"Les\",\"pour\",\"traitement\",\"trith\u00e9rapies\",\"une\",\"unique\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/\",\"name\":\"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg\",\"datePublished\":\"2025-01-03T20:58:54+00:00\",\"dateModified\":\"2025-01-03T20:58:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/","og_locale":"fr_FR","og_type":"article","og_title":"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO - RVH-Synergie.org","og_description":"Pour les patients atteints de maladie pulmonaire obstructive chronique (MPOC), le bud\u00e9sonide-glycopyrrolate-formot\u00e9rol n&rsquo;am\u00e9liore pas les","og_url":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/","og_site_name":"RVH-Synergie","article_published_time":"2025-01-03T20:58:54+00:00","article_modified_time":"2025-01-03T20:58:56+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO","datePublished":"2025-01-03T20:58:54+00:00","dateModified":"2025-01-03T20:58:56+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/"},"wordCount":387,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg","keywords":["BPCO","compare","\u00e9tude","inhalateur","Les","pour","traitement","trith\u00e9rapies","une","unique"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/","url":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/","name":"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg","datePublished":"2025-01-03T20:58:54+00:00","dateModified":"2025-01-03T20:58:56+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1735937934_Une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le.jpg","width":1280,"height":853,"caption":"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/une-etude-compare-les-tritherapies-a-inhalateur-unique-pour-le-traitement-de-la-bpco\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Une \u00e9tude compare les trith\u00e9rapies \u00e0 inhalateur unique pour le traitement de la BPCO"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/3233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=3233"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/3233\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/3234"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=3233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=3233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=3233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}